Form 4: Shattuck Labs Director Receives Stock Option Grant

Sentiment:

Director Equity Grant


Director Helen M. Boudreau was granted 81,000 stock options in Shattuck Labs, Inc. as part of standard equity compensation.

Summary

  • Director Helen M. Boudreau received a grant of 81,000 stock options on May 29, 2026.
  • The options have an exercise price of $5.95 per share.
  • The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the next annual meeting of stockholders.
  • The expiration date for these options is May 29, 2036.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

  • The grant results in potential future dilution for existing shareholders upon exercise.

Risks

  • Market price volatility may impact the future value of the granted options.
  • Continued service requirement creates a dependency on the director's ongoing tenure.

Future Outlook

The options vest in full within one year, contingent upon the director's continued service to the company.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard practice in the biotechnology sector to attract and retain board expertise while aligning incentives with long-term corporate performance.

Comparison to Industry Standards

  • The grant size and vesting schedule are consistent with typical director compensation packages for small-cap biotechnology firms.
  • The use of one-year cliff vesting is a common governance practice to ensure director commitment.

Stakeholder Impact

  • Shareholders may experience minor dilution if these options are exercised in the future.

Next Steps

  • Vesting of options on the earlier of May 29, 2027, or the next annual meeting of stockholders.

Key Dates

DateDescription
05/29/2026Date of grant for the stock options.
06/02/2026Date the Form 4 was filed with the SEC.
05/29/2036Expiration date of the stock options.

Keywords

Shattuck Labs, STTK, Form 4, Director Compensation, Stock Options, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.